Digital health has long been considered the silver-bullet of the healthcare industry, with medical professionals and device manufacturers alike lauding ...

It’s no secret – the life sciences industry lives in an almost constant state of change. Today, change is driven ...

Yesterday, an FDA panel started writing the first chapter in the new novel of modern medicine. With a unanimous recommendation ...

For any industry, the ability to connect data points, maximize equipment efficiency, and extract performance insights are well-documented advantages of ...

The Generic Drug User Fee Amendment (GDUFA II) will go into effect on October 1, 2017.  It will create a ...

1,266,000.   That’s how many web attacks were blocked, not counting successful attacks, per day in May 2017, according to Symantec’s Internet Security Threat Report …and that doesn’t include spam, ...

Co-author and contributions by Megan Weldon Over the next few years, global and multinational pharmaceutical companies will need to achieve ...

In part one of this series, I talked about data integrity at its most basic level – including what it ...

The United States Senate and House of Representatives are both working on new regulations that would significantly impact the cosmetics ...

With a major regulatory deadline approaching this year, pharmaceutical manufacturers across the globe are in varying stages of compliance with ...

Since my first post in this series, the FDA has issued two more warning letters regarding data integrity to drug ...

Over the past decade or more, phrases like “value-based care” and “patient centricity” have evolved to a position of greater ...